Roche declines comment on report of Illumina bid, Bloomberg reports

theflyonthewall.com

Roche (RHHBY) told Bloomberg it does not comment on "market rumors" after Times of London reported last night that the company may attempt to acquire Illumina (ILMN) at $60 per share.

Rates

View Comments (0)